cost of glp-1 medication $350 → $245 → $149: The Price War Has Begun As Interest in GLP-1 Drugs

However, two large meta-analyses of RCTs concerning T2D did not show any significant risk for atrial and ventricular arrhythmias or sudden cardiac death associated with GLP-1RAs

Average weight loss Clinical trials for tirzepatide showed average weight loss of 15-22% of body weight over 72 weeks at the highest doses

[Abstract]2025 Dec 5:590:83-92

16 h underscore the widely acknowledged clinical observation that early intervention is crucial [40,41]

Research is ongoing to establish safety, efficacy, and optimal dosing protocols for human use

Ozempic has been subsidised under Australia's Pharmaceutical Benefits Scheme since mid-2020, and is approved by the Therapeutic Goods Administration only as a type-2 diabetes treatment